病態】急性心筋炎:病態の主座はどこにあるのか?

「はじめに」 心筋炎は心筋を主座とする炎症性疾患と定義され, 臨床像が多彩であるため診断は必ずしも容易でない. 最近は病因による分類がよく用いられ, 感染, 自己免疫やアレルギー, 中毒などがある. 感染による心筋炎において, 以前はリウマチ熱やジフテリアの頻度が高かったが, 最近はウイルスによる頻度が最も高く, 原因が不明の場合(特発性)も多い. 代表的な起因ウイルスにピコナウイルス科のエンテロウイルス属に属するコクサッキーB群ウイルスがあり, 心臓親和性が高く心筋炎のみならず心膜炎の原因として重要である. これまで, 急性心筋炎における心筋細胞傷害機序についてウイルス感染動物や自己免疫性心...

Full description

Saved in:
Bibliographic Details
Published inShinzo Vol. 41; no. 11; pp. 1183 - 1187
Main Authors 大塚, 薫, 寺崎, 文生, 北浦, 泰
Format Journal Article
LanguageJapanese
Published 公益財団法人 日本心臓財団 2009
日本心臓財団
Japan Heart Foundation
Online AccessGet full text
ISSN0586-4488
2186-3016
DOI10.11281/shinzo.41.1183

Cover

Abstract 「はじめに」 心筋炎は心筋を主座とする炎症性疾患と定義され, 臨床像が多彩であるため診断は必ずしも容易でない. 最近は病因による分類がよく用いられ, 感染, 自己免疫やアレルギー, 中毒などがある. 感染による心筋炎において, 以前はリウマチ熱やジフテリアの頻度が高かったが, 最近はウイルスによる頻度が最も高く, 原因が不明の場合(特発性)も多い. 代表的な起因ウイルスにピコナウイルス科のエンテロウイルス属に属するコクサッキーB群ウイルスがあり, 心臓親和性が高く心筋炎のみならず心膜炎の原因として重要である. これまで, 急性心筋炎における心筋細胞傷害機序についてウイルス感染動物や自己免疫性心筋炎動物などのモデルを用いて解明が行われてきた. 本稿では, ウイルス性心筋炎における心筋細胞傷害機序を経時的に明らかにし, その病態の主座について述べる. 「心筋炎の病態生理」 ウイルス性心筋炎の病態は経時的に図のごとく, (1)ウイルスの心筋細胞への感染, (2)自然免疫(innate immunity)による防御, (3)獲得免疫(adaptive immunity)による防御, (4)炎症の消退の4期に分けることができる.
AbstractList 「はじめに」 心筋炎は心筋を主座とする炎症性疾患と定義され, 臨床像が多彩であるため診断は必ずしも容易でない. 最近は病因による分類がよく用いられ, 感染, 自己免疫やアレルギー, 中毒などがある. 感染による心筋炎において, 以前はリウマチ熱やジフテリアの頻度が高かったが, 最近はウイルスによる頻度が最も高く, 原因が不明の場合(特発性)も多い. 代表的な起因ウイルスにピコナウイルス科のエンテロウイルス属に属するコクサッキーB群ウイルスがあり, 心臓親和性が高く心筋炎のみならず心膜炎の原因として重要である. これまで, 急性心筋炎における心筋細胞傷害機序についてウイルス感染動物や自己免疫性心筋炎動物などのモデルを用いて解明が行われてきた. 本稿では, ウイルス性心筋炎における心筋細胞傷害機序を経時的に明らかにし, その病態の主座について述べる. 「心筋炎の病態生理」 ウイルス性心筋炎の病態は経時的に図のごとく, (1)ウイルスの心筋細胞への感染, (2)自然免疫(innate immunity)による防御, (3)獲得免疫(adaptive immunity)による防御, (4)炎症の消退の4期に分けることができる.
Author 大塚, 薫
寺崎, 文生
北浦, 泰
Author_xml – sequence: 1
  fullname: 大塚, 薫
  organization: 大阪医科大学内科学III
– sequence: 1
  fullname: 寺崎, 文生
  organization: 大阪医科大学内科学III
– sequence: 1
  fullname: 北浦, 泰
  organization: 大阪医科大学内科学III
BackLink https://cir.nii.ac.jp/crid/1390001204050222976$$DView record in CiNii
BookMark eNo1UD1LA0EQXUTBGK39A7bRmd29vb1KNPgFARutl83dajYkF7nTQqtcJFVAEAvBXoKI2ooK_pgzSelfcMPF5s3Hm3nMvCUyH3diQ8gqwjoilbiRNmx81Vnn6GrJ5kiJohQVBijmSQk8l3Mu5SJZSVNbBwDpYxCwEqlO7vvj_iDv3o67j-PucPR9PXkZTHo3v18PMyp7_Xn_HH0M8-wtz57y7C7PnvOsl_emVJ4NNpfJwolupWZlFsvkeHfnqLpfqR3uHVS3apUm9bmoCBMwLzRCSi6Q-qg914GA-54Xeci4V5cMQBhtoI4RGM45CB36PKKOq5-wMlkrdGNrVWiniCxwzyAFDh5QSgNfuLHdYqxtIhvqVidu2dioZuciid15Sjdo6syKFAUIFABHRBeYmjo3Bd-nLJDohLYLoWZ6rk-NOktsWyeXSifnNmwZVXiuOLqlAt3-Pxk2dKKamv0BFLePIA
ContentType Journal Article
Copyright 2009 公益財団法人 日本心臓財団
Copyright_xml – notice: 2009 公益財団法人 日本心臓財団
CorporateAuthor 大阪医科大学内科学III
CorporateAuthor_xml – name: 大阪医科大学内科学III
DBID RYH
DOI 10.11281/shinzo.41.1183
DatabaseName CiNii Complete
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2186-3016
EndPage 1187
ExternalDocumentID 130003376810
ah2sinzd_2009_004111_003_1183_1187723981
article_shinzo_41_11_41_1183_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
MOJWN
RJT
RYH
ID FETCH-LOGICAL-j2746-6e935ce688461271a56e9094755d51345b83006eae0b1d0e44406ac74d245bbf3
ISSN 0586-4488
IngestDate Thu Jun 26 23:25:55 EDT 2025
Tue Apr 08 16:40:15 EDT 2025
Wed Sep 03 06:29:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 11
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2746-6e935ce688461271a56e9094755d51345b83006eae0b1d0e44406ac74d245bbf3
OpenAccessLink https://www.jstage.jst.go.jp/article/shinzo/41/11/41_1183/_article/-char/ja
PageCount 5
ParticipantIDs nii_cinii_1390001204050222976
medicalonline_journals_ah2sinzd_2009_004111_003_1183_1187723981
jstage_primary_article_shinzo_41_11_41_1183_article_char_ja
PublicationCentury 2000
PublicationDate 2009
20090000
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – year: 2009
  text: 2009
PublicationDecade 2000
PublicationTitle Shinzo
PublicationTitleAlternate 心臓
PublicationTitle_FL 心臓
Shinzo
PublicationYear 2009
Publisher 公益財団法人 日本心臓財団
日本心臓財団
Japan Heart Foundation
Publisher_xml – name: 公益財団法人 日本心臓財団
– name: 日本心臓財団
– name: Japan Heart Foundation
References 4) Chau DH, Yuan J, Zhang H, et al: Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007; 12: 513-524
2) Martino TA, Petric M, Brown M, et al: Cardiovirulent coxsackieviruses and the decay-accelerating factor(CD55)receptor. Virology 1998; 244: 302-314
20) Seko Y, Matsuda H, Kato K, et al: Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest 1993; 91: 1327-1336
7) Kawai C, Doi Y, Mckenna WJ, Liu PP, Matsumori A: Cardiomyopathy Update. Chapter 4. Dilated cardiomyopathy: A spectrum of conditions linking to viral myocarditis and cardiac remodeling. Tokyo: Elsevier Japan. p.80-110
6) Huang CH, Vallejo JG, Kollias G, Mann DL: Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 2009; 104: 228-237
15) Lowenstein CJ, Hill SL, Lafond-Walker A, et al: Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996; 97: 1837-1843
12) Yamada T, Matsumori A, Sasayama S: Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994; 89: 846-851
17) Mikami S, Kawashima S, Kanazawa K, et al: Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun 1996; 220: 983-989
8) Fairweather D, Frisancho-Kiss S, Rose NR: Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 2005; 15: 17-27
23) Kaya Z, Katus HA, Rose NR: Cardiac troponins and autoimmunity: Their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 2009(in press
26) Tsukada B, Terasaki F, Shimomura H, et al: High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol 2009; 40: 1015-1022
3) Badorff C, Lee GH, Lamphear BJ, et al: Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320-326
21) Maisch B, Trostel-Soeder R, Stechemesser E, et al: Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982; 48: 533-545
14) Yajima T, Yasukawa H, Jeon ES, et al: Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Circulation 2006; 114: 2364-2373
27) 和泉 徹,磯部光章,河合祥雄,ほか:循環器病の診断と治療に関するガイドライン(2002-2003年度合同研究班報告) 急性および慢性心筋炎の診断・治療に関するガイドライン.Circ J 2004; 68(Suppl VI): 1231-1263
1) Bergelson JM, Cunningham JA, Droguett G, et al: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323
28) Gupta S, Markham DW, Drazner MH, Mammen PP: Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 2008; 5: 693-706
16) Hiraoka Y, Kishimoto C, Takada H, et al: Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res 1993; 27: 957-961
22) Caforio AL, Mahon NJ, Tona F, McKenna WJ: Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411-417
5) Silver MA, Kowalczyk D: Coronary microvascular narrowing in acute murine coxsackie B3 myocarditis. Am Heart J 1989; 118: 173-174
18) Yajima T, Knowlton KU: Viral myocarditis: from the perspective of the virus. Circulation 2009; 119: 2615-2624
11) Bryant D, Becker L, Richardson J, et al: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97: 1375-1381
19) Kishimoto C, Kuribayashi K, Masuda T, et al: Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation 1985; 71: 1247-1254
10) Wada H, Saito K, Kanda T, et al: Tumor necrosis factor-alpha(TNF-alpha)plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation 2001; 103: 743-749
9) Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091-1100
24) Fuse K, Kodama M, Ito M, et al: Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol 2003; 134: 403-408
13) Darnell JE Jr: STATs and gene regulation. Science 1997; 277: 1630-1635
25) Kanzaki Y, Terasaki F, Okabe M, et al: Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy. Jpn Circ J 2001; 65: 797-802
References_xml – reference: 6) Huang CH, Vallejo JG, Kollias G, Mann DL: Role of the innate immune system in acute viral myocarditis. Basic Res Cardiol 2009; 104: 228-237
– reference: 3) Badorff C, Lee GH, Lamphear BJ, et al: Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320-326
– reference: 11) Bryant D, Becker L, Richardson J, et al: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97: 1375-1381
– reference: 28) Gupta S, Markham DW, Drazner MH, Mammen PP: Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 2008; 5: 693-706
– reference: 16) Hiraoka Y, Kishimoto C, Takada H, et al: Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res 1993; 27: 957-961
– reference: 2) Martino TA, Petric M, Brown M, et al: Cardiovirulent coxsackieviruses and the decay-accelerating factor(CD55)receptor. Virology 1998; 244: 302-314
– reference: 19) Kishimoto C, Kuribayashi K, Masuda T, et al: Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation 1985; 71: 1247-1254
– reference: 21) Maisch B, Trostel-Soeder R, Stechemesser E, et al: Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982; 48: 533-545
– reference: 5) Silver MA, Kowalczyk D: Coronary microvascular narrowing in acute murine coxsackie B3 myocarditis. Am Heart J 1989; 118: 173-174
– reference: 12) Yamada T, Matsumori A, Sasayama S: Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994; 89: 846-851
– reference: 20) Seko Y, Matsuda H, Kato K, et al: Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest 1993; 91: 1327-1336
– reference: 18) Yajima T, Knowlton KU: Viral myocarditis: from the perspective of the virus. Circulation 2009; 119: 2615-2624
– reference: 24) Fuse K, Kodama M, Ito M, et al: Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol 2003; 134: 403-408
– reference: 9) Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091-1100
– reference: 22) Caforio AL, Mahon NJ, Tona F, McKenna WJ: Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411-417
– reference: 1) Bergelson JM, Cunningham JA, Droguett G, et al: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323
– reference: 25) Kanzaki Y, Terasaki F, Okabe M, et al: Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy. Jpn Circ J 2001; 65: 797-802
– reference: 8) Fairweather D, Frisancho-Kiss S, Rose NR: Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 2005; 15: 17-27
– reference: 10) Wada H, Saito K, Kanda T, et al: Tumor necrosis factor-alpha(TNF-alpha)plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation 2001; 103: 743-749
– reference: 13) Darnell JE Jr: STATs and gene regulation. Science 1997; 277: 1630-1635
– reference: 27) 和泉 徹,磯部光章,河合祥雄,ほか:循環器病の診断と治療に関するガイドライン(2002-2003年度合同研究班報告) 急性および慢性心筋炎の診断・治療に関するガイドライン.Circ J 2004; 68(Suppl VI): 1231-1263
– reference: 4) Chau DH, Yuan J, Zhang H, et al: Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007; 12: 513-524
– reference: 14) Yajima T, Yasukawa H, Jeon ES, et al: Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Circulation 2006; 114: 2364-2373
– reference: 15) Lowenstein CJ, Hill SL, Lafond-Walker A, et al: Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996; 97: 1837-1843
– reference: 23) Kaya Z, Katus HA, Rose NR: Cardiac troponins and autoimmunity: Their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 2009(in press)
– reference: 26) Tsukada B, Terasaki F, Shimomura H, et al: High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol 2009; 40: 1015-1022
– reference: 17) Mikami S, Kawashima S, Kanazawa K, et al: Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun 1996; 220: 983-989
– reference: 7) Kawai C, Doi Y, Mckenna WJ, Liu PP, Matsumori A: Cardiomyopathy Update. Chapter 4. Dilated cardiomyopathy: A spectrum of conditions linking to viral myocarditis and cardiac remodeling. Tokyo: Elsevier Japan. p.80-110
SSID ssib000871993
ssib005879815
ssib058494393
ssj0000605722
ssib002822027
Score 1.7547082
Snippet 「はじめに」 心筋炎は心筋を主座とする炎症性疾患と定義され, 臨床像が多彩であるため診断は必ずしも容易でない. 最近は病因による分類がよく用いられ, 感染, 自己免疫やアレルギー, 中毒などがある. 感染による心筋炎において, 以前はリウマチ熱やジフテリアの頻度が高かったが, 最近はウイルスによる頻度が最も高く,...
SourceID nii
medicalonline
jstage
SourceType Publisher
StartPage 1183
Title 病態】急性心筋炎:病態の主座はどこにあるのか?
URI https://www.jstage.jst.go.jp/article/shinzo/41/11/41_1183/_article/-char/ja
http://mol.medicalonline.jp/library/journal/download?GoodsID=ah2sinzd/2009/004111/003&name=1183-1187j
https://cir.nii.ac.jp/crid/1390001204050222976
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 心臓, 2009, Vol.41(11), pp.1183-1187
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NaxUxcKn1IogoKlat9GCOWzeb7CbBQ9l97qMoCEILvS37kYd94Gux9dJTt9JTQRAPgncpIupVVPDHrG2P_gVnkt12X61gFR4hZD52JrMvmckmE8e57Q80z3Il3IxnhctZwVxV8tIVdMDFIMcceGaX78NwfpHfXwqWJs5U3dMl6_lssXHiuZJ_sSq0gV3xlOwpLHvIFBqgDvaFEiwM5V_ZmCSCKEFkQJIQSxmThJm9C9S0eCQK2oogSUDiPpEMqaJ7BhlofSITkvRJ3CMq-gNDSiLA4SSWJI4Nn8gwtKB-W1FNRbG2pSWHp2DFH2doQfGxvYUdOSWRIM_hyISQiDeqRBTlhRcE0VQIzxpD66OMyImjfgYtRDRgiDpyovpdfNlDvQElBtqwxY8Zib2xdZGjcddQAXLP8IuJjFCQ2EfBAAQtEWt4qMB0XgQ_K4Zo7KJ6hv64vr8z6gzXgQxdCHbtbKJNG1745cIQGnbnG5voq_1f0c7sAcEe63gieBP8ybOcL3GawzXKjZVZTmePCMdShzcvZmoRU04h3rOlZGkLxNN96RBCjLO-EBR3xT541PXQBW7x7EbouFx2NIRLoTrpfsCdVeDissNlTg_C5SYdads_TYItVOLOuArgBQ4hJsJkF-ef2O-UNl8MOH6j5eWO47dw0bnQRGwzkVXkkjMxzC47vYPX2_vbO_Xmy_3Nt_ubu3vfnx982DnYevHz25sGVH388fnr3pfduvpUV-_q6lVdva-rrXoLQXW1M3fFWewnC715t7mPxB36goduqBULCh1K8NmpL2gWQIunuAiCMqCMB7lkoLDOtJfT0tOcg7ecFYKXPsDyAbvqTI5WRvqaM5PRIss9rWlYYBI-nZeypNorcKOC8AbhlHPX9kS6apPOpKex5ZQzN9Z9aTNmraXZY38N6Eu8fValmGwPuMDEbtngCycwISidcqahw9NiGUsIEs2CNcz3Aa4PQQRz_b_ku-Gcsx9lcSXzpjO5_vSZngbffj2_Zd6-X08YzLU
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%97%85%E6%85%8B%E3%80%91%E6%80%A5%E6%80%A7%E5%BF%83%E7%AD%8B%E7%82%8E%EF%BC%9A%E7%97%85%E6%85%8B%E3%81%AE%E4%B8%BB%E5%BA%A7%E3%81%AF%E3%81%A9%E3%81%93%E3%81%AB%E3%81%82%E3%82%8B%E3%81%AE%E3%81%8B%3F&rft.jtitle=%E5%BF%83%E8%87%93&rft.au=%E5%A4%A7%E5%A1%9A%2C+%E8%96%AB&rft.au=%E5%AF%BA%E5%B4%8E%2C+%E6%96%87%E7%94%9F&rft.au=%E5%8C%97%E6%B5%A6%2C+%E6%B3%B0&rft.date=2009&rft.pub=%E5%85%AC%E7%9B%8A%E8%B2%A1%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%BF%83%E8%87%93%E8%B2%A1%E5%9B%A3&rft.issn=0586-4488&rft.eissn=2186-3016&rft.volume=41&rft.issue=11&rft.spage=1183&rft.epage=1187&rft_id=info:doi/10.11281%2Fshinzo.41.1183&rft.externalDocID=article_shinzo_41_11_41_1183_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0586-4488&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0586-4488&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0586-4488&client=summon